Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(Suppl):S220-S227. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0360

View: 5074 Download: 142 Web of Science: 7 Crossref: 8

Original Article

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(3):763-778. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0076

View: 4731 Download: 246 Web of Science: 10 Crossref: 9

Review

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(2):252-262. Published online March 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0099

View: 6138 Download: 291 Web of Science: 37 Crossref: 39

Editorial

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(1):99-101. Published online October 27, 2022

DOI: https://doi.org/10.3350/cmh.2022.0321

View: 4470 Download: 90 Web of Science: 4 Crossref: 5

Surveillance for hepatocellular carcinoma: It is time to move forward

Bo Hyun Kim, Yuri Cho, Joong-Won Park

Clin Mol Hepatol. 2022;28(4):810-813. Published online September 6, 2022

DOI: https://doi.org/10.3350/cmh.2022.0257

View: 4099 Download: 97 Web of Science: 5 Crossref: 5

Review

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 16961 Download: 505 Web of Science: 147 Crossref: 152

1 |

Viewed By 8777	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7581	MAFLD: How is it different from NAFLD?
Viewed By 5473	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5078	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4581	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 293	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 204	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search